1R46 | A:32-323; B:32-323 | STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE |
1R47 | A:32-323; B:32-323 | STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE |
3GXN | A:32-323; B:32-323 | CRYSTAL STRUCTURE OF APO ALPHA-GALACTOSIDASE A AT PH 4.5 |
3GXP | A:32-323; B:32-323 | CRYSTAL STRUCTURE OF ACID-ALPHA-GALACTOSIDASE A COMPLEXED WITH GALACTOSE AT PH 4.5 |
3GXT | A:32-323; B:32-323 | CRYSTAL STRUCTURE OF ALPHA-GALACTOSIDASE A AT PH 4.5 COMPLEXED WITH 1-DEOXYGALACTONIJIRIMYCIN |
3HG2 | A:32-323; B:32-323 | HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 1. EMPTY ACTIVE SITE |
3HG3 | A:32-323; B:32-323 | HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 2. SUBSTRATE BOUND |
3HG4 | A:32-323; B:32-323 | HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 3. COVALENT INTERMEDIATE |
3HG5 | A:32-323; B:32-323 | HUMAN ALPHA-GALACTOSIDASE CATALYTIC MECHANISM 4. PRODUCT BOUND |
3LX9 | A:32-323; B:32-323 | INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES |
3LXA | A:32-323; B:32-323 | INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES |
3LXB | A:32-323; B:32-323 | INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES |
3LXC | A:32-323; B:32-323 | INTERCONVERSION OF HUMAN LYSOSOMAL ENZYME SPECIFICITIES |
3S5Y | A:32-323; B:32-323 | PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE |
3S5Z | A:32-323; B:32-323 | PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE |
3TV8 | A:32-323; B:32-323 | PHARMACOLOGICAL CHAPERONING IN HUMAN ALPHA-GALACTOSIDASE |